77 related articles for article (PubMed ID: 21455275)
1. Analysis of recombinant tagged equilibrative nucleoside transporter 1 (ENT1) expressed in E. coli.
Reyes G; Nivillac NM; Chalsev M; Coe IR
Biochem Cell Biol; 2011 Apr; 89(2):246-55. PubMed ID: 21455275
[TBL] [Abstract][Full Text] [Related]
2. The Equilibrative Nucleoside Transporter (ENT1) can be phosphorylated at multiple sites by PKC and PKA.
Reyes G; Nivillac NM; Karim MZ; Desouza L; Siu KW; Coe IR
Mol Membr Biol; 2011 Sep; 28(6):412-26. PubMed ID: 21809900
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of N48 is required for equilibrative nucleoside transporter 1 (ENT1) function.
Bicket A; Coe IR
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27480168
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells.
Rehan S; Jaakola VP
Protein Expr Purif; 2015 Oct; 114():99-107. PubMed ID: 26162242
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of human equilibrative nucleoside transporter 1.
Huang W; Zeng X; Shi Y; Liu M
Protein Cell; 2017 Apr; 8(4):284-295. PubMed ID: 27995448
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mENT1Delta11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1.
Robillard KR; Bone DB; Park JS; Hammond JR
Mol Pharmacol; 2008 Jul; 74(1):264-73. PubMed ID: 18413666
[TBL] [Abstract][Full Text] [Related]
7. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
8. Disrupted plasma membrane localization and loss of function reveal regions of human equilibrative nucleoside transporter 1 involved in structural integrity and activity.
Nivillac NM; Wasal K; Villani DF; Naydenova Z; Hanna WJ; Coe IR
Biochim Biophys Acta; 2009 Oct; 1788(10):2326-34. PubMed ID: 19699178
[TBL] [Abstract][Full Text] [Related]
9. Purification and properties of the Escherichia coli nucleoside transporter NupG, a paradigm for a major facilitator transporter sub-family.
Xie H; Patching SG; Gallagher MP; Litherland GJ; Brough AR; Venter H; Yao SY; Ng AM; Young JD; Herbert RB; Henderson PJ; Baldwin SA
Mol Membr Biol; 2004; 21(5):323-36. PubMed ID: 15513740
[TBL] [Abstract][Full Text] [Related]
10. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells.
Mangravite LM; Xiao G; Giacomini KM
Am J Physiol Renal Physiol; 2003 May; 284(5):F902-10. PubMed ID: 12527552
[TBL] [Abstract][Full Text] [Related]
11. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.
Chang C; Swaan PW; Ngo LY; Lum PY; Patil SD; Unadkat JD
Mol Pharmacol; 2004 Mar; 65(3):558-70. PubMed ID: 14978234
[TBL] [Abstract][Full Text] [Related]
12. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
Endres CJ; Unadkat JD
Mol Pharmacol; 2005 Mar; 67(3):837-44. PubMed ID: 15557207
[TBL] [Abstract][Full Text] [Related]
13. The life cycle of human equilibrative nucleoside transporter 1: from ER export to degradation.
Nivillac NM; Bacani J; Coe IR
Exp Cell Res; 2011 Jul; 317(11):1567-79. PubMed ID: 21402067
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside transporter expression profiles in human cardiac tissue show striking individual variability with overall predominance of hENT1.
Marvi M; Rose JB; Bang A; Moon BC; Pozeg Z; Ibrahim M; Peniston C; Coe IR
Eur J Pharm Sci; 2010 Dec; 41(5):685-91. PubMed ID: 20883780
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
Hammond JR; Stolk M; Archer RG; McConnell K
Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1.
Osato DH; Huang CC; Kawamoto M; Johns SJ; Stryke D; Wang J; Ferrin TE; Herskowitz I; Giacomini KM
Pharmacogenetics; 2003 May; 13(5):297-301. PubMed ID: 12724623
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F
J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300
[TBL] [Abstract][Full Text] [Related]
18. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
[TBL] [Abstract][Full Text] [Related]
19. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).
Yao SY; Ng AM; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2011 Sep; 286(37):32552-62. PubMed ID: 21795683
[TBL] [Abstract][Full Text] [Related]
20. Characterization and functional analysis of the promoter for the human equilibrative nucleoside transporter gene, hENT1.
Abdulla P; Coe IR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(1):99-110. PubMed ID: 17162590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
